NCT02193503 2023-09-28MVX-ONCO-1 in Patients With Solid TumorMaxivax SAPhase 1 Active not recruiting34 enrolled
NCT00827177 2014-01-24Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid TumorsArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)Phase 1 Completed87 enrolled
NCT00361049 2010-11-05Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantCase Comprehensive Cancer CenterPhase 1 Completed49 enrolled